PlainRecalls
FDA Drug Low Class III Terminated

Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535

Reported: November 20, 2019 Initiated: October 1, 2019 #D-0323-2020

Product Description

Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Sato Pharmaceutical Inc.
Units Affected
210,744 units
Distribution
Nationwide within the United States, Guam and Saipan
Location
Torrance, CA

Frequently Asked Questions

What product was recalled?
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535. Recalled by Sato Pharmaceutical Inc.. Units affected: 210,744 units.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2019. Severity: Low. Recall number: D-0323-2020.